Meeting
2014 ASCO Annual Meeting
Survival of good-risk germ cell tumor patients following post-chemotherapy retroperitoneal lymph node dissection: The effect of bleomycin during induction chemotherapy.
Authors
K. Clint Cary
Indiana University School of Medicine, Department of Urology, Indianapolis, IN
K. Clint Cary , Jose A. Pedrosa , Hristos Z. Kaimakliotis , Timothy A. Masterson , Lawrence H. Einhorn , Richard Foster
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4565)
DOI
10.1200/jco.2014.32.15_suppl.4565
Abstract #
4565
Poster Bd #
133
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Retroperitoneal cancer viability after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in good risk germ cell tumors (GCTs).
First Author: Fadi Taza
Poster
2018 ASCO Annual Meeting
Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts).
First Author: Samuel Funt
Poster
2018 ASCO Annual Meeting
Nasopharengeal carcinoma in children: Demographic, clinical, therapeutic characteristics and long term outcome of 97 patients.
First Author: Rejin Kebudi
Poster
2024 ASCO Genitourinary Cancers Symposium
Inconsistency in the assessment of retroperitoneal lymph node metastasis in patients with testicular cancer: Influence on clinical stage, therapy and relapse rate.
First Author: Tim Nestler